Leadership 12.03.2021
Speaking at Galien Forum and Reuters Total Health Summit, Amgen CEO predicts "proximity biology" will lead to new treatments targeting disease-causing genetic mutations previously considered undruggable.
Patients 11.29.2021
Amgen teams up with StoryCorps to bring real stories from the cancer community to life.
Press Releases 11.29.2021
Science & Innovation 11.23.2021
Responsibility 11.22.2021
COVID-19
Check here for Amgen updates, Amgen product information, public health resources, and other pertinent information related to COVID-19.
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
